No Prescription

No Prescription
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

No Prescription

Alphabetical Index

Categories

Levotiron Eltroxin

No Prescription » Prescription Drugs 10 » Levotiron Eltroxin

Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Levotiron tablets contain the active ingredient levothyroxine sodium (previously known simply as thyroxine sodium in the UK). (NB. Levothyroxine is also available without a brand name ie as the generic medicine.) Levothyroxine is the same as the hormone thyroxine which is produced naturally by the thyroid gland. The thyroid gland produces and releases two thyroid hormones: thyroxine (T4) and tri-iodothyronine (T3). Tri-iodothyronine is the more active thyroid hormone and thyroxine is converted into T3 in various parts of the body. These hormones are responsible for maintaining a normal rate of metabolism in the body. When the thyroid gland is unable to produce normal amounts of thyroxine the level of both thyroid hormones in the blood decreases (hypothyroidism). This results in a reduced rate of metabolism leading to symptoms such as weight gain intolerance to cold and tiredness.Levothyroxine tablets are given to replace the thyroxine that would normally be produced naturally by the thyroid gland. This returns levels of T3 and T4 to normal.Once the thyroid gland becomes unable to produce thyroxine it will generally not return to normal function. This means that once thyroxine replacement is started it usually needs to be taken for the rest of a personĘs life.The daily dose should preferably be taken before breakfast.What is it used for?Underproduction of thyroid hormones by the thyroid gland (hypothyroidism).

Buy Levotiron Eltroxin and other Prescription Drugs 10 products online at Medstore.

4976
Buy Online at Medstore - Click Here!

About Levotiron Eltroxin:

Product Type: Prescription Drugs 10

Levotiron ( Eltroxin Generic Levothyroxine sodium )

Levotiron (Eltroxin Generic Levothyroxine sodium)

Eltroxin Generic Levothyroxine sodium

0 1 mg 100 tabs Eltroxin Generic Levothyroxine sodium Levotiron

View more Prescription Drugs 10

Previous Product  Next Product

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.